Trial Details
COMPLETEDBasic Information
| Clinical ID | c1238 |
|---|---|
| Identifier | NCT00092508 |
| Trial Title | CORE: A Study of OPC-6535 With Asacol in Maintaining Ulcerative Colitis (UC) Remission |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: OPC-6535|DRUG: Asacol |
Participant Information
| Sponsor | Otsuka Pharmaceutical Development & Commercialization, Inc. |
|---|---|
| City | Huntsville |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-05-04 |
|---|---|
| Primary Completion Date | - |
| Completion Date | 2025-05-07 |